Liminatus Pharma, Inc. (LIMN)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 11, 2025 | CORRESP | Neutral/Informational | High | Liminatus Pharma, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. The company aims for the registrat… | Read Filing EDGAR |
| Jul. 25, 2025 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a response to the SEC's comments regarding their Registration Statement on Form S-1 filed on June 24, 2025. The correspondence outlines the co… | Read Filing EDGAR |
| Jul. 3, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of Liminatus Pharma, Inc.'s registration statement on Form S-1 and has issued comments requiring clarification on specific points. Notably, … | Read Filing EDGAR |